These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35047415)

  • 21. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern.
    Morris CP; Luo CH; Amadi A; Schwartz M; Gallagher N; Ray SC; Pekosz A; Mostafa HH
    Clin Infect Dis; 2022 Apr; 74(8):1419-1428. PubMed ID: 34272947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    Taboada B; Vazquez-Perez JA; Muñoz-Medina JE; Ramos-Cervantes P; Escalera-Zamudio M; Boukadida C; Sanchez-Flores A; Isa P; Mendieta-Condado E; Martínez-Orozco JA; Becerril-Vargas E; Salas-Hernández J; Grande R; González-Torres C; Gaytán-Cervantes FJ; Vazquez G; Pulido F; Araiza-Rodríguez A; Garcés-Ayala F; González-Bonilla CR; Grajales-Muñiz C; Borja-Aburto VH; Barrera-Badillo G; López S; Hernández-Rivas L; Perez-Padilla R; López-Martínez I; Ávila-Ríos S; Ruiz-Palacios G; Ramírez-González JE; Arias CF
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
    Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
    Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus.
    Qiang XL; Xu P; Fang G; Liu WB; Kou Z
    Infect Dis Poverty; 2020 Mar; 9(1):33. PubMed ID: 32209118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak.
    Chen J; Hilt EE; Li F; Wu H; Jiang Z; Zhang Q; Wang J; Wang Y; Li Z; Tang J; Yang S
    Front Public Health; 2020; 8():567621. PubMed ID: 33072702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.
    Chiara M; Horner DS; Gissi C; Pesole G
    Mol Biol Evol; 2021 May; 38(6):2547-2565. PubMed ID: 33605421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population.
    Banerjee A; Ray S; Vorselaars B; Kitson J; Mamalakis M; Weeks S; Baker M; Mackenzie LS
    Int Immunopharmacol; 2020 Sep; 86():106705. PubMed ID: 32652499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance.
    Rockett RJ; Draper J; Gall M; Sim EM; Arnott A; Agius JE; Johnson-Mackinnon J; Fong W; Martinez E; Drew AP; Lee C; Ngo C; Ramsperger M; Ginn AN; Wang Q; Fennell M; Ko D; Hueston L; Kairaitis L; Holmes EC; O'Sullivan MN; Chen SC; Kok J; Dwyer DE; Sintchenko V
    Nat Commun; 2022 May; 13(1):2745. PubMed ID: 35585202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).
    Nguyen TT; Pathirana PN; Nguyen T; Nguyen QVH; Bhatti A; Nguyen DC; Nguyen DT; Nguyen ND; Creighton D; Abdelrazek M
    Sci Rep; 2021 Feb; 11(1):3487. PubMed ID: 33568759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19).
    Tizaoui K; Zidi I; Lee KH; Ghayda RA; Hong SH; Li H; Smith L; Koyanagi A; Jacob L; Kronbichler A; Shin JI
    Int J Biol Sci; 2020; 16(15):2906-2923. PubMed ID: 33061805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid genomic surveillance of SARS-CoV-2 in a dense urban community of Kathmandu Valley using sewage samples.
    Napit R; Manandhar P; Chaudhary A; Shrestha B; Poudel A; Raut R; Pradhan S; Raut S; Rajbhandari PG; Gurung A; Rajbhandari RM; Dixit SM; Schwind JS; Johnson CK; Mazet JK; Karmacharya DB
    PLoS One; 2023; 18(3):e0283664. PubMed ID: 36996055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.
    Jia HL; Li P; Liu HJ; Zhong JY; Qin PZ; Su WZ; Zheng YF; Li KB; Zeng Q; Li JH; Li LZ; Cao L; Wu JB; Chen YY; Jia LL; Song HB; Zhang QW; Yang G; Jing CX; Bo XC; Zhang ZB; Di B; Xiao CL; Ni M
    J Clin Microbiol; 2021 Jul; 59(8):e0007921. PubMed ID: 33952598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip.
    Kumar M; Gulati S; Ansari AH; Phutela R; Acharya S; Azhar M; Murthy J; Kathpalia P; Kanakan A; Maurya R; Vasudevan JS; S A; Pandey R; Maiti S; Chakraborty D
    Elife; 2021 Jun; 10():. PubMed ID: 34106048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants.
    Mertens J; Coppens J; Loens K; Le Mercier M; Xavier BB; Lammens C; Vandamme S; Jansens H; Goossens H; Matheeussen V
    Clin Microbiol Infect; 2022 Jan; 28(1):124-129. PubMed ID: 34537361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2.
    Richardson TG; Fang S; Mitchell RE; Holmes MV; Davey Smith G
    EBioMedicine; 2021 Feb; 64():103228. PubMed ID: 33548839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens.
    Kuchinski KS; Nguyen J; Lee TD; Hickman R; Jassem AN; Hoang LMN; Prystajecky NA; Tyson JR
    Int J Infect Dis; 2022 Jan; 114():51-54. PubMed ID: 34757201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of machine learning models to predict RT-PCR results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with influenza-like symptoms using only basic clinical data.
    Langer T; Favarato M; Giudici R; Bassi G; Garberi R; Villa F; Gay H; Zeduri A; Bragagnolo S; Molteni A; Beretta A; Corradin M; Moreno M; Vismara C; Perno CF; Buscema M; Grossi E; Fumagalli R
    Scand J Trauma Resusc Emerg Med; 2020 Dec; 28(1):113. PubMed ID: 33261629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.